The biotechnology sector often rides a rollercoaster of high hopes and sharp setbacks, and few cases illustrate this better than the recent plunge in Exelixis’ stock value following the release of data from its STELLAR-303 trial. Focused on zanzalintinib, an experimental drug for metastatic
Imagine a world where the brain's fundamental energy processes, long thought to be set in stone, are suddenly redefined by a single discovery that could alter the course of treatment for devastating neurological conditions. Researchers from prestigious institutions have recently unveiled a
The startling reality that over 30% of adults may carry dangerous fat deposits deep within their abdomen or liver, even without visible signs of obesity, has sparked intense discussion in the medical community. This hidden fat, often undetectable through traditional measures like body mass index
Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, particularly in the realm of innovative technologies in the pharmaceutical industry. With his deep understanding of cutting-edge treatments, Ivan is the perfect
In the quiet corridors of cancer research, a seismic shift is stirring for those battling multiple myeloma, a blood cancer that relentlessly challenges both patients and clinicians, igniting hope for a breakthrough. Picture a patient, exhausted after rounds of treatment, hoping for a breakthrough
Diving into the intricate world of brain circuits and decision-making, we’re thrilled to speak with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research, development, and cutting-edge tech innovations. Ivan has been at the forefront of exploring how computational
